Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Christopher I. Carswell"'
Autor:
LaVerne A. Mooney, Dan Bridges, Karen L. Woolley, Angela Cairns, Wendy P Battisti, James A Gurr, Elizabeth Wager, Carol Sanes-Miller, Teresa Peña, B. Jane Moore, Keith Veitch, Yvonne E Yarker, Leslie Citrome, Lise Baltzer, Christopher I. Carswell
Publikováno v:
Annals of Internal Medicine. 163:461-464
This updated Good Publication Practice (GPP) guideline, known as GPP3, builds on earlier versions and provides recommendations for individuals and organizations that contribute to the publication of research results sponsored or supported by pharmace
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 10, Iss 9, Pp 4339-4351 (2013)
International Journal of Environmental Research and Public Health
Volume 10
Issue 9
Pages 4339-4351
International Journal of Environmental Research and Public Health
Volume 10
Issue 9
Pages 4339-4351
The pharmaceutical industry's profitability depends on identifying and successfully developing new drug candidates while trying to contain the increasing costs of drug development. It is actively searching for new sources of innovative compounds and
Autor:
Andrew Briggs, Josephine M. Mauskopf, Christopher I. Carswell, Dan Greenberg, Federico Augustovski, Don Husereau, Michael Drummond, Cheers Task Force, Elizabeth Loder, Stavros Petrou, David Moher
Publikováno v:
Cost Effectiveness and Resource Allocation : C/E
BMC Medicine
BMC Medicine
Economic evaluations of health interventions pose a particular challenge for reporting. There is also a need to consolidate and update existing guidelines and promote their use in a user friendly manner. The Consolidated Health Economic Evaluation Re
Publikováno v:
The Patient: Patient-Centered Outcomes Research. 5:279-294
While the application of conjoint analysis and discrete-choice experiments in health are now widely accepted, a healthy debate exists around competing approaches to experimental design. There remains, however, a paucity of experimental evidence compa
Autor:
Elizabeth Robinson, Christopher I. Carswell, Mirjana Stojkovic, Amanda J. Wheeler, Jane Vanderpyl
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 36:651-663
Summary What is known and objective: Long-acting injectable (LAI) antipsychotics are recommended for those people with a preference for this form of treatment and those who experience negative outcomes due to non-adherence with oral medication. LAI a
Publikováno v:
The Patient: Patient-Centered Outcomes Research. 1:259-263
Autor:
Dan Greenberg, Andrew Briggs, Christopher I. Carswell, Michael Drummond, Stavros Petrou, Josephine Mauskopf, David Moher, Elizabeth Loder, Don Husereau, Federico Augustovski
Publikováno v:
PharmacoEconomics. 33(5)
Publikováno v:
Disease Management & Health Outcomes. 11:745-765
Rheumatoid arthritis is a progressive, disabling disease which can lead to long-term deformity and disability. Leflunomide is a disease-modifying antirheumatic drug (DMARD) approved to reduce signs and symptoms, inhibit structural damage and improve
Autor:
Karen L. Goa, Christopher I. Carswell
Publikováno v:
Drugs. 63:407-414
Losartan is an orally active, selective, nonpeptide, angiotensin II AT(1) receptor antagonist. Losartan 50 or 100 mg/day was significantly more effective than placebo in reducing the incidence of a doubling of serum creatinine, end-stage renal diseas
Publikováno v:
Drugs. 62:2075-2085
▴ Rosuvastatin is a hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitor used in the treatment of patients with dyslipidaemia. Rosuvastatin is not extensively metabolised and has a low propensity for drug interactions. ▴ In well designe